- Coco Gauff to Lead U.S. Billie Jean King Cup Team in Delray Beach Homecoming
- Mackenzie McDonald and Tommy Paul Stake U.S. to 2-0 Davis Cup Lead
- Australian Open Champions Djokovic, Sabalenka Headline Dubai
- Hall of Fame Announces Initiatives for Black History Month, Featuring Althea Gibson
- Roland Garros Unveils 2023 Official Poster Art
- 2023 Australian Open Sets Grand Slam Attendance Record
- Djokovic on track to play U.S. Open, but out of Indian Wells and Miami
- Emma Raducanu Joins Austin Field
- Rafael Nadal, Roger Federer Congratulate Novak Djokovic on 10th Australian Open Title
- Post-Australian Open ATP rankings: Djokovic back to No. 1, Paul and Shelton make major moves
- Novak Djokovic Tops Stefanos Tsitsipas for 10th Australian Open Title, 22nd Grand Slam
- Noah Rubin’s “Behind The Racquet” with Marion Bartoli • Tennis | 10sBalls
- Aryna Sabalenka Edges Elena Rybakina in Dramatic Australian Open Final
- Ricky’s preview and pick for the Australian Open final: Djokovic vs. Tsitsipas
- Djokovic, Tsitsipas set up showdown for No. 1 in Australian Open final
Tennis Anti-Doping Program Statement Regarding Daniel Evans
- Updated: July 3, 2017

Following the statement made by Daniel Evans today, the Tennis Anti-Doping Programme (TADP) can confirm the following:
- On 24 April 2017, Mr Evans, a 27-year-old player from Great Britain, provided an anti-doping sample to the TADP in association with his participation in the Barcelona Open, an ATP World Tour event, held in Barcelona, Spain.
- That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory in Montreal, Canada, and was found to contain cocaine and its metabolite. Cocaine is a Non-Specified substance prohibited under category S6 of the 2017 WADA Prohibited List (stimulants), and therefore is also prohibited under the TADP.
- In accordance with Article 2.1 of the TADP, Mr Evans was charged on 16 June with an Anti-Doping Rule Violation.
- Mr Evans has accepted the finding of cocaine in his sample collected on 24 April.
- As positive tests for Non-Specified Substances carry a mandatory Provisional Suspension, Mr Evans will be provisionally suspended with effect from 26 June, under Article 8.3.1(c) of the 2017 TADP, pending determination of the case.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.